Interleukin-12 and Interferon-Gamma Production In The Recently Diagnosed Type 1 Diabetic Patients and High-Risk First Degree Relatives

1Mabrouk Ghonaim, 2Rawhia El-Edel, 3Nabil El-Kafrawi and Aly Abdel Rheim

Departments of 1Microbiology and Immunology, 2Clinical pathology and 3Internal Medicine Faculty of Medicine, Menoufiya and Alexandria Universities.

The pathogenesis of type 1 (insulin-dependent) diabetes mellitus (IDDM) is believed to result from a defective pattern of cytokine secretion. Cytokines released by macrophages/monocytes and T lymphocytes may have an initial role in b-cell damage. The aim of this study was to estimate serum IL-12 and IFN-g levels and to assess their in vitro production by peripheral blood mononuclear cells (PBMCs) from high-risk first degree relatives of type 1 diabetic patients and from recently diagnosed IDDM patients. The study included 12 patients with recent-onset IDDM, 24 high-risk relatives and 10 healthy controls. Whole blood cell cultures were done in the presence of phytohaemagglutinin (PHA) for 48 hours. IL-12 and IFN-g were measured in the culture supernates and sera using enzyme immunoassay. Results showed significantly higher serum IL-12 levels in IDDM patients (p< 0.01) and high-risk relatives (p< 0.001) and serum IFN-g levels in patients (p< 0.001 ) and high-risk relatives (p< 0.01) as compared to that of the controls. There was significantly (p< 0.01) higher levels of IFN-g in culture supernates obtained from patients and high-risk relatives than that of the controls. However, the levels of IL-12 in culture supernates were non-significantly higher in both patients and relatives when compared to that of the controls. In conclusion, IL-12 is overproduced in the prediabetic phase leading to a shift in T helper cells toward Th1 type, culminating in increased production of IFN-g which may lead to insulitis and b-cell destruction and diabetes. Neutralization of this effect in high-risk relatives may prevent the development of the disease.